LAT Research   Report issue

For profit Phase 4
Founded: Buenos Aires Argentina (2010)

Organization Overview

First Clinical Trial
2011
NCT01549236
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now